Systolic Heart Failure Stage D (Disorder)
1 clinical trials · Condition
◉ Watch Systolic Heart Failure Stage D (Disorder)
| Record | Firm | Date |
|---|---|---|
| The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation (NCT04217135) | Kaohsiung Veterans General Hospital. | 2017-01-01 |
Track Systolic Heart Failure Stage D (Disorder) automatically
Every clearance here is in the API, with alerts when new ones post.